Valneva SE

VLA

Company Profile

  • Business description

    Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

  • Contact

    6 Rue Alain Bombard
    Saint-Herblain44800
    FRA

    T: +33 228073710

    E: [email protected]

    https://www.valneva.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    713

Stocks News & Analysis

stocks

Is this the $80 billion elephant Warren Buffett has been waiting for?

Morningstar’s Greg Warren says Berkshire may have little choice but to take a hard look at this huge potential acquisition.
stocks

Tesla: Board announces new pay package for CEO Elon Musk

A key provision of the new award is that Musk must remain in a senior leadership position at Tesla.
stocks

New ASX share on our best ideas list

This undervalued miner is unappreciated by the market.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,021.7099.701.12%
CAC 407,632.0185.851.14%
DAX 4023,757.69331.721.42%
Dow JONES (US)44,173.64585.061.34%
FTSE 1009,128.3059.720.66%
HKSE24,774.5141.060.17%
NASDAQ21,053.58403.451.95%
Nikkei 22540,607.38316.680.79%
NZX 50 Index12,838.27154.231.22%
S&P 5006,329.9491.931.47%
S&P/ASX 2008,763.1099.401.15%
SSE Composite Index3,602.1318.820.53%

Market Movers